My scientific interests are based around meta-research and immune cell biology, particularly how immune cells are capable of performing wide ranging functions and how they adapt to different environmental cues. During my masters degree, I investigated the presence of fibroblast subtypes and the role of PGE2 signalling in fibrosis. I completed my PhD in the labs of Iwan Evans & Martin Zeidler at the University of Sheffield investigating the existence of macrophage subtypes in Drosophila. Following a brief post-doc in Cambridge, I moved to London, investigating the role of neutrophils and T-cells in ischaemia reperfusion injury (IRI) in the Voisin lab. I left the bench behind in 2023 and now work to further the adoption and use of preprints in the biosciences with ASAPbio.
In addition, I have active interests in science communication, open-access, career development and community building. I host the Preprints in Motion podcast where we highlight ECRs and the benefits of preprinting and founded the UK & EU postdoc community to provide a place for postdocs to support one-another and share resources. I have also featured on international radio stations (BBC Radio 4, ORF & German National radio) to communicate the importance of preprints in addition to having written for outlets such as The Scientist and the British Society for Cell Biology.
I am a member of IGDORE and the Ronin Institute and I also sit on the scientific advisory board for Europe PMC.
I am always happy to collaborate on projects of interest & talk all things preprint - just get in touch. Can be found on all the socials until we collectively choose one; BlueSky | Twitter | Threads
Outside of the lab I enjoy climbing, the outdoors, photography, a cocktail (or six), fine-dining, guitars, comedy, live-music and adrenaline-fueled adventures.
PhD in Cell & molecular biology, 2019
Sheffield University
MRes in Immunobiology, 2015
Newcastle University
BSc in Biomedical Science, 2013
Northumbria University
We investigated the role of preprints in the first 10 months of the COVID-19 pandemic